Placental endocrine insufficiency programs anxiety, deficits in cognition and atypical social behaviour in offspring

David J Harrison1, Hugo D J Creeth1, Hannah R Tyson1

  • 1Biomedicine Division, School of Biosciences, Cardiff University, Cardif CF10 3AX, UK.

Insights

Elevated PHLDA2 gene expression in fetal growth restriction (FGR) is linked to offspring anxiety and cognitive deficits. Placental insufficiency programs these atypical behaviors, impacting later life mental health.

Area of Science:

  • Developmental Biology
  • Neuroscience
  • Genetics

Background:

  • Abnormal PHLDA2 gene expression is observed in the placenta of human babies with fetal growth restriction (FGR).
  • Previous mouse models showed that increased Phlda2 expression causes placental endocrine insufficiency and FGR.
  • FGR and suboptimal maternal care are associated with increased risk of mental health disorders.

Purpose of the Study:

  • To investigate the behavioral consequences of elevated Phlda2 expression in offspring.
  • To determine if placental endocrine insufficiency programs long-term behavioral alterations.

Main Methods:

  • Mouse model with elevated Phlda2 expression was used.
  • Behavioral tests assessed anxiety, cognition, and social interaction in adult offspring.
  • Transcriptomic analysis of key brain regions (hippocampus, hypothalamus, amygdala) was performed.

Main Results:

  • Offspring with elevated Phlda2 exhibited increased anxiety-like behaviors, cognitive deficits, and atypical social behaviors, particularly males.
  • Transcriptomic analysis revealed alterations in relevant brain regions.
  • Control groups confirmed that placental endocrine insufficiency, not just the gene change, drove these outcomes.

Conclusions:

  • Elevated PHLDA2, a common FGR alteration, is associated with negative behavioral outcomes in offspring.
  • Placental endocrine insufficiency can program atypical behaviors, highlighting its role in later-life disorders.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.2K